82 related articles for article (PubMed ID: 10606166)
21. The CD34+90+ cell dose does not predict early engraftment of autologous blood stem cells as well as the total CD34+ cell dose.
Stewart DA; Guo D; Luider J; Auer I; Klassen J; Morris D; Chaudhry A; Brown C; Russell JA; Gluck S
Bone Marrow Transplant; 2000 Feb; 25(4):435-40. PubMed ID: 10723588
[TBL] [Abstract][Full Text] [Related]
22. Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignancies.
Bolwell BJ; Pohlman B; Rybicki L; Sobecks R; Dean R; Curtis J; Andresen S; Koo A; Mineff V; Kalaycio M; Sweetenham JW
Bone Marrow Transplant; 2007 Sep; 40(5):437-41. PubMed ID: 17618321
[TBL] [Abstract][Full Text] [Related]
23. Ex vivo manipulation of hematopoietic stem and progenitor cells.
Kanz L; Brugger W; Scheding S
Stem Cells; 1998; 16 Suppl 1():199-204. PubMed ID: 11012163
[TBL] [Abstract][Full Text] [Related]
24. Post-thaw viable CD34(+) cell count is a valuable predictor of haematopoietic stem cell engraftment in autologous peripheral blood stem cell transplantation.
Lee S; Kim S; Kim H; Baek EJ; Jin H; Kim J; Kim HO
Vox Sang; 2008 Feb; 94(2):146-52. PubMed ID: 18028260
[TBL] [Abstract][Full Text] [Related]
25. Comparison of two different methods for CD34+ selection and T cell depletion in peripheral blood stem cell grafts--our experiences with CellPro, E rosetting and CliniMACS technique.
Poloucková A; Vodvárková A; Kobylka P; Hrubá A; Gasová Z; Marinov I; Fales I; Sedlácek P; Kozák T; Starý J
Neoplasma; 2001; 48(5):374-81. PubMed ID: 11845982
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometric enumeration and immunophenotyping of hematopoietic stem and progenitor cells.
Gratama JW; Sutherland DR; Keeney M; Papa S
J Biol Regul Homeost Agents; 2001; 15(1):14-22. PubMed ID: 11388740
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the human CD34+ hematopoietic progenitor cell compartment during the second trimester of pregnancy.
Lim FT; Kanhai HH; Falkenburg JH
Haematologica; 2005 Feb; 90(2):173-9. PubMed ID: 15710568
[TBL] [Abstract][Full Text] [Related]
28. Characterization of banked umbilical cord blood hematopoietic progenitor cells and lymphocyte subsets and correlation with ethnicity, birth weight, sex, and type of delivery: a Cord Blood Transplantation (COBLT) Study report.
Cairo MS; Wagner EL; Fraser J; Cohen G; van de Ven C; Carter SL; Kernan NA; Kurtzberg J
Transfusion; 2005 Jun; 45(6):856-66. PubMed ID: 15934982
[TBL] [Abstract][Full Text] [Related]
29. Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma.
Yoon DH; Sohn BS; Jang G; Kim EK; Kang BW; Kim C; Kim JE; Kim S; Lee DH; Lee JS; Park SJ; Park CJ; Huh J; Suh C
Transfusion; 2009 Sep; 49(9):1890-900. PubMed ID: 19453991
[TBL] [Abstract][Full Text] [Related]
30. Peripheral blood and BM CD34+ CD38- cells show better resistance to cryopreservation than CD34+ CD38+ cells in autologous stem cell transplantation.
Ojeda-Uribe M; Sovalat H; Bourderont D; Brunot A; Marr A; Lewandowski H; Chabouté V; Peter P; Henon P
Cytotherapy; 2004; 6(6):571-83. PubMed ID: 15764022
[TBL] [Abstract][Full Text] [Related]
31. Genetically engineered fluorescent cell marker for labeling CD34+ hematopoietic stem cells.
Ye K; Jin S; Schultz JS
Biotechnol Prog; 2004; 20(2):561-5. PubMed ID: 15059003
[TBL] [Abstract][Full Text] [Related]
32. Prediction of target CD34 positive cells following leukopheresis in children with neuroblastoma.
Schroeder H; Kamperis K; Grunnet N; Hokland P
Pediatr Blood Cancer; 2006 Jun; 46(7):786-92. PubMed ID: 16333829
[TBL] [Abstract][Full Text] [Related]
33. [Therapeutic neovascularization with autologous bone marrow CD34+ cells transplantation in hindlimb ischemia].
Zhang HK; Zhang N; Wu LH; Jin W; Li M; Feng H; Zhao HG; Chen XD; Yang CH
Zhonghua Wai Ke Za Zhi; 2005 Oct; 43(19):1275-8. PubMed ID: 16271229
[TBL] [Abstract][Full Text] [Related]
34. CD34(+) CD38(-) and CD34(+) HLA-DR(-) cells in BM stem cell grafts correlate with short-term engraftment but have no influence on long-term hematopoietic reconstitution after autologous transplantation.
Zubair AC; Kao G; Daley H; Schott D; Freedman A; Ritz J
Cytotherapy; 2006; 8(4):399-407. PubMed ID: 16923616
[TBL] [Abstract][Full Text] [Related]
35. Enumeration of bone marrow 'homing' haemopoietic stem cells from G-CSF-mobilised normal donors and influence on engraftment following allogeneic transplantation.
Spencer A; Jackson J; Baulch-Brown C
Bone Marrow Transplant; 2001 Dec; 28(11):1019-22. PubMed ID: 11781610
[TBL] [Abstract][Full Text] [Related]
36. Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells.
Jang YK; Jung DH; Jung MH; Kim DH; Yoo KH; Sung KW; Koo HH; Oh W; Yang YS; Yang SE
Ann Hematol; 2006 Apr; 85(4):212-25. PubMed ID: 16391912
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of cyclosporin A-induced autologous graft-versus-host disease after peripheral blood stem cell transplantation by utilizing selected CD34(+) cells.
Miura Y; Ueda M; Takami A; Shiobara S; Nakao S; Hess AD
Bone Marrow Transplant; 2003 Oct; 32(8):785-90. PubMed ID: 14520422
[TBL] [Abstract][Full Text] [Related]
38. [The hematopoietic stem cell: biology and clinical applications].
Consolini R; Legitimo A; Calleri A
Pathologica; 2001 Feb; 93(1):2-14. PubMed ID: 11294014
[TBL] [Abstract][Full Text] [Related]
39. Growth factors mobilize CXCR4 low/negative primitive hematopoietic stem/progenitor cells from the bone marrow of nonhuman primates.
Mahmud N; Patel H; Hoffman R
Biol Blood Marrow Transplant; 2004 Oct; 10(10):681-90. PubMed ID: 15389434
[TBL] [Abstract][Full Text] [Related]
40. Quality assurance issues in CD34 cell enumeration.
Turpen P
Am Clin Lab; 1998 Apr; 17(3):12-4. PubMed ID: 10179698
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
